Skip to article

Why Specialty Pharmacy Coordination Needs to Start at the Point of Care

Why Specialty Pharmacy Coordination Needs to Start at the Point of Care
Share

Specialty medications are among the most advanced and consequential therapies in modern medicine. They also come with some of the most complicated paths to actually reaching a patient. Between the moment a prescription is written and the moment therapy starts, a prescription passes through benefits verification, prior authorization, pharmacy routing, and affordability checks, usually at different points in time, run by different teams, using systems that don't share what they know with each other.


That gap, the distance between prescribing and the pharmacy counter rather than either point on its own, is where specialty pharmacy programs succeed or struggle.


What happens when coordination is downstream

When benefits verification and prior authorization happen after a prescription is already released, delays compound instead of resolving. A prescription routes to a pharmacy before anyone has confirmed it's covered. Prior authorization starts only once a rejection surfaces. Affordability and 340B eligibility get checked after financial exposure has already begun.


Each step is manageable in isolation. Stacked in sequence, they add real distance between the prescription and the first dose, and they consume clinical team time on follow-up calls and status checks that a better-sequenced workflow wouldn't require in the first place. The clinical team's attention is the scarcest resource in a specialty pharmacy program, and today, a lot of it goes toward chasing information that should have been available from the start.

Moving coordination to the point of care

The alternative is to run these checks before the prescription moves, not after. Verify benefits and initiate prior authorization at the point of care. Confirm affordability and complete 340B pre-qualification and compliance checks before financial exposure begins. Optimize routing to the right dispensing pharmacy before the prescription is released, rather than redirecting it after a delay has already occurred.


That's the shift LRx360 is built around: a specialty pharmacy performance enablement platform, co-developed by Longitude Rx and powered by Innovaccer's Gravity Platform, that unifies specialty pharmacy data across payers, pharmacies, and wholesalers and embeds intelligence directly into the workflow from the moment a prescription is written.

LRx360 is not a dispensing pharmacy, a billing platform, or a replacement for clinical judgment. It's the coordination layer underneath a program that already exists, built to let care teams act earlier, with more clarity, instead of reconstructing what happened after the fact.

What changes across the journey

Benefits and prior authorization move earlier. Eligibility and PA initiation happen at the point of care, ahead of when a prescription is released rather than in response to a denial.


Routing gets optimized upfront. Prescriptions are directed to the most appropriate dispensing pharmacy, with internal pharmacy fill prioritized where it applies, before the prescription leaves the point of care rather than after a delay surfaces the issue.

Affordability and 340B checks happen before exposure, not after. Pre-qualification and compliance validation run ahead of financial commitment. LRx360 supports health systems in maintaining 340B program compliance and reduces the operational complexity of running that program well; it is not a savings or revenue tool, and shouldn't be framed as one.

Visibility follows the prescription end to end. One continuous view from order entry through therapy initiation, including cases where a prescription is filled outside the health system, so care teams aren't guessing what happened next.

Where care teams' time goes instead

The goal isn't fewer people involved in specialty pharmacy. It's a program where the clinical team's time goes toward the moments that actually need their judgment: the patient conversation, the adherence check, the escalation, rather than reconstructing where a prescription is stuck. When the administrative weight of chasing status moves off a care team's plate, what's left is the part of the job that brought them into specialty pharmacy in the first place.


For program leadership, the same shift shows up as visibility: where time-to-therapy delays happen, which patients are at risk of falling out of the process, and what's actually driving performance, brought together instead of scattered across systems that don't talk to each other.

Stay connected with Innovaccer

Subscribe to receive the latest insights, updates, and stories from healthcare innovation.

Please provide your email address if you'd like to receive our monthly newsletter. You can unsubscribe at any time.

Keep reading

View allView all